CLC number:
On-line Access: 2022-08-12
Received: 2022-03-23
Revision Accepted: 2022-05-31
Crosschecked: 2022-08-12
Cited: 0
Clicked: 1003
Weihuan HU, Yuhang ZHU, Yan WU, Fangfang WANG, Fan QU. Impact of COVID-19 pandemic on the pregnancy outcomes of women undergoing assisted reproductive techniques (ARTs): a systematic review and meta-analysis[J]. Journal of Zhejiang University Science B,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1631/jzus.B2200154 @article{title="Impact of COVID-19 pandemic on the pregnancy outcomes of women undergoing assisted reproductive techniques (ARTs): a systematic review and meta-analysis", %0 Journal Article TY - JOUR
COVID-19大流行对接受辅助生殖技术(ART)的妇女妊娠结局的影响:系统评价和荟萃分析1浙江大学医学院附属妇产科医院,中国杭州,310006 2大连医科大学,中国大连,116000 目的:2019年全球新型冠状病毒病肺炎(COVID-19)的爆发导致大多数辅助生殖技术(ART)治疗的暂停。然而,随着最近中国成功控制了大流行,公众迫切需要恢复全面的生殖保健。因此,本文讨论COVID-19大流行是否对女性生育能力和接受ART治疗的妇女的妊娠结局有任何不利影响。 方法:使用中英文电子数据库进行了系统评价和荟萃分析。二分类结局总结为患病率和比值比(OR),连续结局总结为标准化均数差(SMD),置信度为95%。使用Stata/SE 15.1和R 4.1.2评估偏倚风险和亚组分析。 结论:结果显示,与COVID-19前接受ART治疗的妇女相比,COVID-19大流行后接受ART治疗的妇女在临床妊娠率(1.07,0.97~1.19;I2=0.0%)、流产率(0.95,0.79~1.14;I2=38.4%)、胚胎冷冻保存率(2.90,0.17~48.13;I2=85.4%)和卵母细胞冷冻保留率(0.30,0.03~3.65;I2=81.6%)等方面没有显著差异。该评价为妇科医生提供了额外的证据,以指导在COVID-19大流行期间接受ART治疗的妇女的管理。 关键词组: Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article
Reference[1]AharonD, GounkoD, LeeJA, et al., 2021. The impact of the coronavirus disease 19 pandemic on early pregnancy outcomes among patients undergoing in vitro fertilization treatment. Womens Health Rep, 2(1):473-478. [2]AlloteyJ, FernandezS, BonetM, et al., 2020. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ, 370:m3320. [3]ChenLX, WuHP, LiR, et al., 2021. Impacts and prompts of COVID-19 outbreaking on assisted reproductive technology services in Beijing. Chin J Reprod Contracept, 41(1):12-17 (in Chinese). [4]ChmielewskaB, BarrattI, TownsendR, et al., 2021. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health, 9(6):e759-e772. [5]de GruijterNM, NajaM, PeckhamH, et al., 2021. A systematic review exploring the bidirectional relationship between puberty and autoimmune rheumatic diseases. Pediatr Rheumatol, 19:47. [6]DekkersOM, EggerM, AltmanDG, et al., 2012. Distinguishing case series from cohort studies. Ann Intern Med, 156(1):37-40. [7]Dell'UtriC, ManzoniE, CiprianiS, et al., 2020. Effects of SARS CoV-2 epidemic on the obstetrical and gynecological emergency service accesses. What happened and what shall we expect now? Eur J Obstet Gynecol Reprod Biol, 254:64-68. [8]GreeneNH, KilpatrickSJ, WongMS, et al., 2020. Impact of labor and delivery unit policy modifications on maternal and neonatal outcomes during the coronavirus disease 2019 pandemic. Am J Obstet Gynecol MFM, 2(4):100234. [9]HeWH, LiuXQ, FengL, et al., 2020. Impact of SARS-CoV-2 on male reproductive health: a review of the literature on male reproductive involvement in COVID-19. Front Med, 7:594364. [10]HitosugiM, MotozawaY, KidoM, et al., 2006. Traffic injuries of the pregnant women and fetal or neonatal outcomes. Forensic Sci Int, 159(1):51-54. [11]HuangJW, ZhouXY, LuSJ, et al., 2020. Dialectical behavior therapy-based psychological intervention for woman in late pregnancy and early postpartum suffering from COVID-19: a case report. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(5):394-399. [12]KahnLG, TrasandeL, LiuML, et al., 2021. Factors associated with changes in pregnancy intention among women who were mothers of young children in New York City following the COVID-19 outbreak. JAMA Netw Open, 4(9):e2124273. [13]KolanskaK, HoursA, JonquièreL, et al., 2021. Mild COVID-19 infection does not alter the ovarian reserve in women treated with ART. Reprod BioMed Online, 43(6):1117-1121. [14]LablancheO, SalleB, PerieMA, et al., 2022. Psychological effect of COVID-19 pandemic among women undergoing infertility care, a French cohort-PsyCovART Psychological effect of COVID-19: PsyCovART. J Gynecol Obstet Hum Reprod, 51(1):102251. [15]Levi-SettiPE, CirilloF, ImmediataF, et al., 2021. First trimester pregnancy outcomes in a large IVF center from the Lombardy County (Italy) during the peak COVID-19 pandemic. Sci Rep, 11:16529. [16]LiKZ, ChenG, HouHY, et al., 2021. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod BioMed Online, 42(1):260-267. [17]LindbergLD, VandeVusseA, MuellerJ, et al., 2020. Early impacts of the COVID-19 pandemic: findings from the 2020 Guttmacher Survey of Reproductive Health Experiences. Guttmacher Institute, New York. https://www.guttmacher.org/report/early-impacts-covid-19-pandemic-findings-2020-guttmacher-survey-reproductive-health [Accessed on Mar. 1, 2021]. [18]MayeurA, BinoisO, GallotV, et al., 2020. First follow-up of art pregnancies in the context of the COVID-19 outbreak. Eur J Obstet Gynecol Reprod Biol, 253:71-75. [19]PetoJ, AlwanNA, GodfreyKM, et al., 2020. Universal weekly testing as the UK COVID-19 lockdown exit strategy. Lancet, 395(10234):1420-1421. [20]QiaoJ, 2020. What are the risks of COVID-19 infection in pregnant women? Lancet, 395(10226):760-762. [21]RangchaikulP, VenketaramanV, 2021. SARS-CoV-2 and the immune response in pregnancy with Delta variant considerations. Infect Dis Rep, 13(4):993-1008. [22]ShawJ, TozourJ, BlakemoreJK, et al., 2021. Universal SARS-CoV-2 polymerase chain reaction screening and assisted reproductive technology in a coronavirus disease 2019 pandemic epicenter: screening and cycle outcomes from a New York City fertility center. Fertil Steril, 116(4):980-987. [23]TrawickE, BabayevE, PotapragadaN, et al., 2022. Fertility preservation during the COVID-19 pandemic: modified but uncompromised. Womens Health Rep, 3(1):31-37. [24]UK Health Security Agency, 2022. Living safely with respiratory infections, including COVID-19. https://www.gov.uk/guidance/covid-19-coronavirus-restrictions-what-you-can-and-cannot-do#covid-19-remains-a-risk [Accessed on Apr. 1, 2022]. [25]VisserJA, SchipperI, LavenJSE, et al., 2012. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol, 8(6):331-341. [26]WangM, YangQY, RenX, et al., 2021. Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and in vitro fertilization outcomes: a retrospective cohort study. eClinicalMedicine, 38:101013. [27]WellsG, SheaBJ, O'ConnellD, et al., 2000. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. https://www.researchgate.net/publication/261773681 [Accessed on Mar. 1, 2021]. [28]WHO (World Health Organization), 2020a. Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance, 20 March 2020. https://apps.who.int/iris/handle/10665/331506 [Accessed on Mar. 1, 2021]. [29]WHO, 2020b. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who.int/zh/news-room/detail/01-05-2020-statement-on-the-third-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-coronavirus-disease-(covid-19)[Accessed on Mar. 1, 2021]. [30]WHO, 2022. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int [Accessed on Mar. 1, 2021]. [31]WongSF, ChowKM, LeungTN, et al., 2004. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol, 191(1):292-297. Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou
310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE |
Open peer comments: Debate/Discuss/Question/Opinion
<1>